3
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Clinical Significance of Serum Type-III Procollagen Arninopropeptide in Hepatitis B Virus-Related Liver Diseases

, , , , , , , & show all
Pages 533-538 | Received 24 Oct 1988, Accepted 09 Jan 1989, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chi-Hang Wong, Sophie Ka-Ping Chan, Henry Lik-Yuen Chan & Stephen Kwok-Wing Tsui. (2006) The Molecular Diagnosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Critical Reviews in Clinical Laboratory Sciences 43:1, pages 69-101.
Read now

Articles from other publishers (20)

Soon Sun Kim, Jae Chul Hwang, Sun Gyo Lim, Seon Joo Ahn, Jae Youn Cheong & Sung Won Cho. (2014) Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis. American Journal of Gastroenterology 109:8, pages 1223-1233.
Crossref
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Chang Bum Bae, Han Gyeol Kim, Young Jip Kim, Seung Kyung Lee, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Won Cho & Jae Youn Cheong. (2012) Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clinical Biochemistry 45:18, pages 1564-1567.
Crossref
Ying-Ying Yang, Yi-Tsau Huang, Kuei-Chuan Lee, Fa-Yauh Lee, Tzung-Yan Lee, Ming-Chih Hou, Han-Chieh Lin & Shou-Dong Lee. (2008) Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. Clinical Science 116:1, pages 71-79.
Crossref
Ying-Ying Yang, Kuei-Chuan Lee, Yi-Tsau Huang, Ying-Wen Wang, Ming-Chih Hou, Fa-Yauh Lee, Han-Chieh Lin & Shou-Dong Lee. (2008) Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. Journal of Hepatology 49:1, pages 25-33.
Crossref
Xiao-Dong Zhu. (2004) New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology. World Journal of Gastroenterology 10:16, pages 2327.
Crossref
Žarko Babić, Ante Bilić, Dobroslav Babić, Vjekoslav Jagić, Branko Nikolić & Martina Sunić. (2003) Predictive role of serum procollagen III peptide and Knodell’s index in survival prognosis of patients with hepatitis B virus liver cirrhosis. Wiener Klinische Wochenschrift 115:9, pages 302-308.
Crossref
Giovanni Battista Gabrielli, Franco Capra, Massimo Casaril, Stefano Squarzoni, Patrizia Tognella, Roberta Dagradi, Elena De Maria, Romano Colombari, Roberto Corrocher & Giorgio De Sandre. (1997) Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis. Clinica Chimica Acta 265:1, pages 21-31.
Crossref
Eiji Ishimura, Yoshiki Nishizawa, Shigeichi Shoji & Hirotoshi Morii. (1996) Serum type III, IV collagens and timp in patients with type II diabetes mellitus. Life Sciences 58:16, pages 1331-1337.
Crossref
Takato Ueno, Seishu Tamaki, Hiroshi Sugawara, Sadataka Inuzuka, Takuji Torimura, Michio Sata & Kyuichi Tanikawa. (1996) Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. Journal of Hepatology 24:2, pages 177-184.
Crossref
G. Zöhrens, T. Armbrust, K. -H. Meyer Zum Büschenfelde & G. Ramadori. (1994) Interferon-α2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection. Digestive Diseases and Sciences 39:9, pages 2007-2013.
Crossref
Julio Collazos & Fernando Díaz. (1994) Procollagen-III peptide concentrations in serum of patients with chronic active hepatitis compared with mild hepatic disorders. Clinical Biochemistry 27:3, pages 189-191.
Crossref
J. Carlos Teran, Kevin D. Mullen, Jay H. Hoofnagle & Arthur J. McCullough. (1994) Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-α. Hepatology 19:4, pages 849-856.
Crossref
Yuan-Jen Wang, Shou-Dong Lee, Mao-Chih Hsieh, Han-Chieh Lin, Fa-Yauh Lee, Shyh-Haw Tsay, Yang-Te Tsai, Oliver Yoa-Pu Hu, Ming-Lu King & Kwang-Juei Lo. (1994) A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis. Journal of Hepatology 21:5, pages 872-877.
Crossref
J. Enrique Domínguez-Muñoz, Gianpiero Manes, Markus Büchler & Peter Malfertheiner. (1993) Assessment of the fibrogenetic activity in chronic pancreatitis. International journal of pancreatology 14:3, pages 253-259.
Crossref
Manal Shahin, Detlef Schuppan, Rüdiger Waldherr, Juha Risteli, Leila Risteli, Eeva-Riitta Savolainen, Christine Oesterling, Hosna M. Abdel Rahman, Abdul M. El Sahly, Samia M. Abdel Razek, Omar El Ruby, Armin Koch & Helmut K. Seitz. (1992) Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology 15:4, pages 637-644.
Crossref
E. Lotterer, A.M. Gressner, J. Kropf, E. Grobe, D. von Knebel & J. Bircher. (1992) Higher levels of aminoterminal type III procollagen peptide, and laminin in alcoholic in nonalcoholic cirrhosis of equal severity. Journal of Hepatology 14:1, pages 71-77.
Crossref
R. Beukers, R.A.A. van Zanten & S.W. Schalm. (1992) Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. Journal of Hepatology 14:1, pages 22-29.
Crossref
Mario Plebani & Angelo Burlina. (1991) Biochemical markers of hepatic fibrosis. Clinical Biochemistry 24:3, pages 219-239.
Crossref
G. ADLER, J. KROPF, E. GROBE & A. M. GRESSNER. (1990) Follow-up of the serum levels of extracellular matrix components in acute and chronic pancreatitis. European Journal of Clinical Investigation 20:s1, pages 494-501.
Crossref
G. ADLER, J. KROPF, E. GROBE & A. M. GRESSNER. (2008) Follow-up of the serum levels of extracellular matrix components in acute and chronic pancreatitis. European Journal of Clinical Investigation 20:5, pages 494-501.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.